Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Gaudium IVF And Women Health Days Payable?
Gaudium IVF And Women HealthNSE:GAUDIUMIVF +4.99%20 Days Payable is 88.88 as of Mar. 2026, which is 161% above its 10-year median of 33.99. GuruFocus rates NSE:GAUDIUMIVF with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Gaudium IVF And Women Health ranks better than 82.4% on this metric.
The historical rank and industry rank for Gaudium IVF And Women Health's Days Payable or its related term are showing as below:
NSE:GAUDIUMIVF'
s Days Payable Range Over the Past 10 Years
Min: 20.7 Med: 33.99 Max: 173.59
Current: 173.59
During the past 5 years, Gaudium IVF And Women Health's highest Days Payable was 173.59. The lowest was 20.70. And the median was 33.99.
NSE:GAUDIUMIVF's Days Payable is ranked better than 82.4% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 57.32
vs NSE:GAUDIUMIVF: 173.59
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GAUDIUMIVF vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Gaudium IVF And Women Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaudium IVF And Women Health Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gaudium IVF And Women Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Gaudium IVF And Women Health's Days Payable falls into.
Gaudium IVF And Women Health Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a Days Payable of 88.88 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Gaudium IVF And Women Health and its competitors. This is 161% above median its historical median of 33.99. Over the past decade, Gaudium IVF And Women Health's Days Payable has ranged from 20.70 to 173.59. According to the industry distribution chart, Gaudium IVF And Women Health ranks #107 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 17.6%.
Is Gaudium IVF And Women Health's Days Payable too high?
Gaudium IVF And Women Health's current Days Payable of 88.88 is 161% above median its 10-year median of 33.99. Over the past 10 years, this metric has ranged from a low of 20.70 to a high of 173.59. The Healthcare Providers & Services industry median Days Payable is 57.32. Gaudium IVF And Women Health's value of 88.88 is 55.1% above this industry median. Based on the distribution chart, Gaudium IVF And Women Health ranks #107 out of 608 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Gaudium IVF And Women Health has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Gaudium IVF And Women Health's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gaudium IVF And Women Health ranks #107 out of 608 companies for Days Payable. This places Gaudium IVF And Women Health in the top 18% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.32. Gaudium IVF And Women Health's value of 88.88 is 55.1% above this benchmark. Historically, Gaudium IVF And Women Health's own Days Payable has ranged from 20.70 to 173.59 over the past decade. While the company's 10-year median is 33.99 vs. the industry median of 57.32, Gaudium IVF And Women Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.32, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaudium IVF And Women Health's current Days Payable of 88.88 is 55.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Gaudium IVF And Women Health and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaudium IVF And Women Health's current Days Payable is 88.88, which is 161% above median its own 10-year median of 33.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaudium IVF And Women Health stock overvalued right now?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a current Days Payable of 88.88. The current Days Payable is 88.88, which is 161% above median its 10-year median of 33.99 and 55.1% above the Healthcare Providers & Services industry median of 57.32. Gaudium IVF And Women Health's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Gaudium IVF And Women Health (NSE:GAUDIUMIVF), the current Days Payable is 88.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gaudium IVF And Women Health Ltd is engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), Egg Freezing, and laser assisted embryo implantation, amongst others. The company derives the majority of its revenue from business of providing IVF treatment in bundled packages which includes injections, Ovum/Egg Pickup, Embryo Creation and Embryo Transfer.
20GF Score
Get the complete analysis for NSE:GAUDIUMIVF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GAUDIUMIVF has been successfully added to your 
